Cargando…
A case of complete resection of prostate stromal sarcoma after neoadjuvant chemotherapy
INTRODUCTION: Prostatic stromal sarcoma is an extremely rare malignancy of the prostate with a poor prognosis. CASE PRESENTATION: A 65‐year‐old man presented with dyschezia, and computed tomography showed a large prostate mass. The diagnosis was prostate stromal sarcoma by transrectal needle biopsy....
Autores principales: | Hodotsuka, Naoto, Suzuki, Yasutomo, Suzuki, Kyota, Honda, Yuichiro, Endo, Shuma, Kuribayashi, Eigo, Obayashi, Kotaro, Minowa, Tadaaki, Hatori, Tsutomu, Kondo, Yukihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315243/ https://www.ncbi.nlm.nih.gov/pubmed/37405039 http://dx.doi.org/10.1002/iju5.12596 |
Ejemplares similares
-
Initial detection of circulating tumor cells from metastatic prostate cancer patients with a novel small device
por: Obayashi, Kotaro, et al.
Publicado: (2019) -
Nivolumab therapy for metastatic collecting duct carcinoma after nephrectomy: A case report
por: Yasuoka, Shotaro, et al.
Publicado: (2018) -
Expression of epithelial-Mesenchymal transition related markers in Plasmacytoid Urothelial carcinoma of the urinary bladder
por: Nomura, Shunichiro, et al.
Publicado: (2020) -
Nephrostomy catheter entering the right renal vein during an exchange procedure: A case report and literature review
por: Akatsuka, Jun, et al.
Publicado: (2021) -
Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy: DYRK2 is associated with survival in bladder cancer
por: Nomura, Shunichiro, et al.
Publicado: (2015)